zhōng chéng yào中成药shuō míng shū说明书xīn新guī dìng规定：ràng让yòng yào用药gèng更ān quán安全
Recently, China issued a new regulation regarding traditional Chinese medicine (TCM).
Starting from July 2026, if the instructions for TCM still state 'unclear' under sections like 'side effects' and 'contraindications,' those medicines will no longer be allowed to be sold.
This means many TCM products on the market will face rectification or production suspension.
In the past, many TCM instruction leaflets were written quite simply.
Patients often did not know who should avoid the medicine or what adverse reactions might occur after taking it when reading the instructions.
This posed risks to many people's medication safety.
The new regulation requires pharmaceutical companies to thoroughly investigate and write these details clearly and comprehensively.
Many people worry whether they will no longer be able to buy Chinese medicine in the future.
Experts say there is no need to worry too much.
This rectification mainly targets medicines of poor quality, incomplete information, or those rarely seen on the market.
Common medicines we often use, like cold and cough remedies, have mostly completed the instruction updates.
For everyone, this is a very good thing.
With clearer instructions, we can take medicine more confidently and safely.
In the future, by reading the instructions, we will know whether a medicine suits our own constitution.
Of course, experts also remind that it is best to listen to doctors' advice before taking medicine.
This change not only protects everyone's health but also makes the development of traditional Chinese medicine more scientific and standardized.
Although some medicines will leave the market, those that remain will give us greater peace of mind.